Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Dual Therapy vs Bismuth Quadruple Therapy for H. pylori Rescue
NCT04678492Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esomeprazole and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Helicobacter pylori eradication. Started Dec 2020; status: completed.
02
Drugs
esomeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04678492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04678492.